Human Immunoglobulin G

Name
Human Immunoglobulin G
Accession Number
DBCAT003547
Description

Not Available

Drugs
DrugDrug Description
Human immunoglobulin GA purified form of human immunoglobulin G and other proteins used to treat immunodeficiency and a wide variety of autoimmune disorders.
Human Rho(D) immune globulinA solution of antibodies used to prevent isoimmunization of Rho(D) negative patients exposed to Rho(D) positive blood in pregnancy or transfusion.
Human cytomegalovirus immune globulinA solution of immune globulin G against cytomegalovirus used to prevent transmission of cytomegalovirus after organ transplants.
Human vaccinia virus immune globulinA purified gamma globulin used to treat vaccinia infections where skin is compromised, or infections of the eyes, mouth, or other areas where vaccinia infections present a special hazard.
Human botulinum neurotoxin A/B immune globulinHuman-derived IgG antibodies against botulism toxin types A and B used in the treatment of infant botulism.
Efgartigimod alfaA neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive and chronic inflammatory demyelinating polyneuropathy.
Drugs & Drug Targets
DrugTargetType
Human immunoglobulin GLow affinity immunoglobulin gamma Fc region receptor III-Btarget
Human immunoglobulin GLow affinity immunoglobulin gamma Fc region receptor III-Atarget
Human immunoglobulin GHigh affinity immunoglobulin gamma Fc receptor Itarget
Human immunoglobulin GLow affinity immunoglobulin gamma Fc region receptor II-atarget
Human immunoglobulin GLow affinity immunoglobulin gamma Fc region receptor II-btarget
Human immunoglobulin GLow affinity immunoglobulin gamma Fc region receptor II-ctarget
Human immunoglobulin GPutative high affinity immunoglobulin gamma Fc receptor IBtarget
Human immunoglobulin GComplement C3target
Human immunoglobulin GComplement C4-Atarget
Human immunoglobulin GComplement C4-Btarget
Human immunoglobulin GComplement C5target
Human Rho(D) immune globulinRhesus blood group D antigentarget
Efgartigimod alfaIgG receptor FcRn large subunit p51target